Atlas Trials

A Trial of SHR-1701 With or Without Famitinib in Patients With Advanced or Metastatic NSCLC

Clinical trial NCT04699968 · WITHDRAWN

Trial details

NCT number
NCT04699968
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small-Cell Lung Cancer
Start date
2021-01-15
Primary completion
2021-11-15
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.